Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Stay updated on the volatile share price of Recursion, a biotech company with a maturing pipeline and potential for growth ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities.

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

A middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...

A comprehensive retrospective celebrating the extraordinary career of Wim Wenders, this landmark event marks the 79-year-old ...

Together with his postdoc, Shiga, he chose African trypanosomes as a target and trypan red as the drug, and soon established ... Shortly before the discovery of compound 606, Uhlenhuth had adapted ...

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...

Electron transport in bilayer graphene exhibits a pronounced dependence on edge states and a nonlocal transport mechanism, ...